These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1275 related articles for article (PubMed ID: 32788292)

  • 1. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
    Arunachalam PS; Wimmers F; Mok CKP; Perera RAPM; Scott M; Hagan T; Sigal N; Feng Y; Bristow L; Tak-Yin Tsang O; Wagh D; Coller J; Pellegrini KL; Kazmin D; Alaaeddine G; Leung WS; Chan JMC; Chik TSH; Choi CYC; Huerta C; Paine McCullough M; Lv H; Anderson E; Edupuganti S; Upadhyay AA; Bosinger SE; Maecker HT; Khatri P; Rouphael N; Peiris M; Pulendran B
    Science; 2020 Sep; 369(6508):1210-1220. PubMed ID: 32788292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
    Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
    Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between SARS-CoV-2 and the type I interferon response.
    Sa Ribero M; Jouvenet N; Dreux M; Nisole S
    PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Schulte-Schrepping J; Reusch N; Paclik D; Baßler K; Schlickeiser S; Zhang B; Krämer B; Krammer T; Brumhard S; Bonaguro L; De Domenico E; Wendisch D; Grasshoff M; Kapellos TS; Beckstette M; Pecht T; Saglam A; Dietrich O; Mei HE; Schulz AR; Conrad C; Kunkel D; Vafadarnejad E; Xu CJ; Horne A; Herbert M; Drews A; Thibeault C; Pfeiffer M; Hippenstiel S; Hocke A; Müller-Redetzky H; Heim KM; Machleidt F; Uhrig A; Bosquillon de Jarcy L; Jürgens L; Stegemann M; Glösenkamp CR; Volk HD; Goffinet C; Landthaler M; Wyler E; Georg P; Schneider M; Dang-Heine C; Neuwinger N; Kappert K; Tauber R; Corman V; Raabe J; Kaiser KM; Vinh MT; Rieke G; Meisel C; Ulas T; Becker M; Geffers R; Witzenrath M; Drosten C; Suttorp N; von Kalle C; Kurth F; Händler K; Schultze JL; Aschenbrenner AC; Li Y; Nattermann J; Sawitzki B; Saliba AE; Sander LE;
    Cell; 2020 Sep; 182(6):1419-1440.e23. PubMed ID: 32810438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
    Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG
    Front Immunol; 2020; 11():1636. PubMed ID: 32670298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
    Park JH; Lee HK
    Front Immunol; 2020; 11():2145. PubMed ID: 32983174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
    Silvin A; Chapuis N; Dunsmore G; Goubet AG; Dubuisson A; Derosa L; Almire C; Hénon C; Kosmider O; Droin N; Rameau P; Catelain C; Alfaro A; Dussiau C; Friedrich C; Sourdeau E; Marin N; Szwebel TA; Cantin D; Mouthon L; Borderie D; Deloger M; Bredel D; Mouraud S; Drubay D; Andrieu M; Lhonneur AS; Saada V; Stoclin A; Willekens C; Pommeret F; Griscelli F; Ng LG; Zhang Z; Bost P; Amit I; Barlesi F; Marabelle A; Pène F; Gachot B; André F; Zitvogel L; Ginhoux F; Fontenay M; Solary E
    Cell; 2020 Sep; 182(6):1401-1418.e18. PubMed ID: 32810439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell landscape of immunological responses in patients with COVID-19.
    Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
    Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
    Mann ER; Menon M; Knight SB; Konkel JE; Jagger C; Shaw TN; Krishnan S; Rattray M; Ustianowski A; Bakerly ND; Dark P; Lord G; Simpson A; Felton T; Ho LP; ; Feldmann M; ; Grainger JR; Hussell T
    Sci Immunol; 2020 Sep; 5(51):. PubMed ID: 32943497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemically comparing host immunity between survived and deceased COVID-19 patients.
    Wang F; Hou H; Yao Y; Wu S; Huang M; Ran X; Zhou H; Liu Z; Sun Z
    Cell Mol Immunol; 2020 Aug; 17(8):875-877. PubMed ID: 32541836
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.
    Chang AJ; Croix M; Kenney P; Baron S; Hicar MD
    Pediatr Infect Dis J; 2020 Nov; 39(11):e366-e367. PubMed ID: 33021596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.